The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126078351 12607835 1 I 20160704 20160722 20160729 20160729 EXP FR-ASTRAZENECA-2016SE80869 ASTRAZENECA 65.00 YR M Y 0.00000 20160729 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126078351 12607835 1 PS BRILIQUE TICAGRELOR 1 Oral 720 MG 22433 90 MG TABLET BID
126078351 12607835 2 SS FUROSEMIDE. FUROSEMIDE 1 Oral 80 MG Y U 0 20 MG QD
126078351 12607835 3 SS DIAMOX SEQUELS ACETAZOLAMIDE 1 Oral 10 MG Y U 0 2.5 MG QD
126078351 12607835 4 SS LOVENOX ENOXAPARIN SODIUM 1 Subcutaneous 0
126078351 12607835 5 SS OMNIPAQUE IOHEXOL 1 Intravenous (not otherwise specified) 185.0ML ONCE/SINGLE ADMINISTRATION 185 ML 0 185 ML INTRAVENOUS INFUSION
126078351 12607835 6 SS AGRASTAT TIROFIBAN HYDROCHLORIDE 1 Intravenous (not otherwise specified) SINGLE DOSE 0
126078351 12607835 7 SS BISOCE BISOPROLOL 1 Oral 10 MG Y 0 2.5 MG QD
126078351 12607835 8 C ASPEGIC ASPIRIN DL-LYSINE 1 Oral 0 250 MG QD
126078351 12607835 9 C PLAVIX CLOPIDOGREL BISULFATE 1 Oral DAILY 0
126078351 12607835 10 C MORPHINE MORPHINE 1 0
126078351 12607835 11 C RAMIPRIL. RAMIPRIL 1 Oral 0 20 MG QD
126078351 12607835 12 C TAHOR ATORVASTATIN CALCIUM 1 Oral 0 80 MG QD
126078351 12607835 13 C KARDEGIC ASPIRIN LYSINE 1 Oral 0 75 MG QD
126078351 12607835 14 C PRIMPERAN METOCLOPRAMIDE HYDROCHLORIDE 1 0
126078351 12607835 15 C PARACETAMOL ACETAMINOPHEN 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126078351 12607835 1 Myocardial infarction
126078351 12607835 2 Myocardial infarction
126078351 12607835 3 Myocardial infarction
126078351 12607835 4 Chest pain
126078351 12607835 5 Scan
126078351 12607835 6 Coronary angioplasty
126078351 12607835 8 Chest pain
126078351 12607835 9 Myocardial infarction
126078351 12607835 11 Myocardial infarction
126078351 12607835 12 Cardiovascular event prophylaxis
126078351 12607835 13 Myocardial infarction

Outcome of event

Event ID CASEID OUTC COD
126078351 12607835 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126078351 12607835 Chills
126078351 12607835 Malaise
126078351 12607835 Pruritus
126078351 12607835 Rash maculo-papular
126078351 12607835 Rash vesicular

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126078351 12607835 1 20160701 0
126078351 12607835 2 20160701 20160706 0
126078351 12607835 3 20160701 20160705 0
126078351 12607835 4 20160630 20160630 0
126078351 12607835 5 20160701 20160701 0
126078351 12607835 6 20160702 20160702 0
126078351 12607835 7 20160701 20160705 0
126078351 12607835 8 20160630 20160630 0
126078351 12607835 9 20160630 20160630 0
126078351 12607835 11 20160701 20160706 0
126078351 12607835 12 20160701 0
126078351 12607835 13 20160701 0